Evidence map›Paper›PMID 41275218›Full record

ArticleBMC public health2025

The prevalence of intimate partner violence against women diagnosed with infertility in China: a national cross-sectional study.

Yu Fu, Fei Kong, Kailibinuer Kayimu, Guimin Hao, Haining Luo, Yun Sun, Yanwen Xu, Meisong Lu, Yunxia Cao, Junli Zhao and 6 more

Abstract read
In one paragraph

Article in BMC public health, 2025. The graph could read no effect estimate from its abstract, so it casts no vote on the map. Cited by 1 paper.

0numbers the graph read from it
0cells of the map it votes in
1citing papers in PubMed
–field-weighted citation impact
1 · What the graph read from it

What it found

Each row is one number read from the abstract, on the scale the paper reported it, with its interval. Left of the dashed line favours the treatment, right favours the comparator. Under each row is the sentence it came from. New to these charts? A ten-minute tutorial.

The abstract states no effect estimate the extractor could read, or names no intervention and outcome on the map, so this paper lights no cell and moves no belief. It is still indexed, cited and linked below.

2 · The registry

The trial behind it

Trials whose registry record cites this paper, or whose number appears in the abstract. A trial that started after this paper was published is citing it as background, not reporting it.

Neither the registry nor the abstract names a trial number. If this is a trial report, that itself is worth knowing.

3 · Its place in the literature

Who cites it

1 citing paper in PubMed.

  1. Impact of intimate partner violence onFrontiers in medicine · 2026
    Article
4 · The record

Corrections and comments

PubMed lists nothing against this paper. Absence here is not a guarantee, only a check that was made.

5 · Who and what money

Authors and funding

16 authors.

Yu Fu *Department of Obstetrics and Gynecology, National Clinical Research Center for Obstetrical and Gynecological Diseases, State Key Laboratory of Female Fertility Promotion, Ministry of Education Key Laboratory of Assisted Reproduction, Center for Reproductive Medicine, Peking University Third Hospital, Beijing, 100191, China.
Fei Kong *Department of Obstetrics and Gynecology, National Clinical Research Center for Obstetrical and Gynecological Diseases, State Key Laboratory of Female Fertility Promotion, Ministry of Education Key Laboratory of Assisted Reproduction, Center for Reproductive Medicine, Peking University Third Hospital, Beijing, 100191, China.
Kailibinuer KayimuDepartment of Obstetrics and Gynecology, National Clinical Research Center for Obstetrical and Gynecological Diseases, State Key Laboratory of Female Fertility Promotion, Ministry of Education Key Laboratory of Assisted Reproduction, Center for Reproductive Medicine, Peking University Third Hospital, Beijing, 100191, China.
Guimin HaoDepartment of Reproductive Medicine, The Second Hospital of Hebei Medical University, Shijiazhuang, China.
Haining LuoCenter for Reproductive Medicine, Tianjin Central Hospital of Obstetrics and Gynecology, Tianjin, China.
Yun SunCenter for Reproductive Medicine, School of Medicine, Ren Ji Hospital, Shanghai, China.
Yanwen XuReproductive Medicine Center, Guangdong Provincial Key Laboratory of Reproductive Medicine, Clinical Research Center for Obstetrical and Gynecological Diseases of Guangdong Province, The First Affiliated Hospital, Sun Yat-sun University, Guangzhou, China.
Meisong LuDepartment of Reproductive, The First Affiliated Hospital of Harbin Medical University, Harbin, China.
Yunxia CaoDepartment of Obstetrics and Gynecology, Reproductive Medicine Center, The First Affiliated Hospital, Anhui Medical University, Hefei, China.
Junli ZhaoCenter for Reproductive Medicine, General Hospital of Ningxia Medical University, Yinchuan, China.
Xiru LiuReproductive Medicine Center, The First Affiliated Hospital of Chongqing Medical University, Chongqing, China.
Ze WuDepartment of Reproductive Medicine, NHC Key Laboratory of Healthy Birth and Birth Defect Prevention in Western China, The First People's Hospital of Yunnan Province & the Affiliated Hospital of Kunming University of Science and Technology, Kunming, China.
Fang LiuDepartment of Obstetrics and Gynecology, National Clinical Research Center for Obstetrical and Gynecological Diseases, State Key Laboratory of Female Fertility Promotion, Ministry of Education Key Laboratory of Assisted Reproduction, Center for Reproductive Medicine, Peking University Third Hospital, Beijing, 100191, China.
Tian TianDepartment of Obstetrics and Gynecology, National Clinical Research Center for Obstetrical and Gynecological Diseases, State Key Laboratory of Female Fertility Promotion, Ministry of Education Key Laboratory of Assisted Reproduction, Center for Reproductive Medicine, Peking University Third Hospital, Beijing, 100191, China.
Yuanyuan WangDepartment of Obstetrics and Gynecology, National Clinical Research Center for Obstetrical and Gynecological Diseases, State Key Laboratory of Female Fertility Promotion, Ministry of Education Key Laboratory of Assisted Reproduction, Center for Reproductive Medicine, Peking University Third Hospital, Beijing, 100191, China. yyuanwang@163.com.
Jie QiaoDepartment of Obstetrics and Gynecology, National Clinical Research Center for Obstetrical and Gynecological Diseases, State Key Laboratory of Female Fertility Promotion, Ministry of Education Key Laboratory of Assisted Reproduction, Center for Reproductive Medicine, Peking University Third Hospital, Beijing, 100191, China. jie.qiao@263.net.

Funding

National Key Research and Development Program of China 2022YFC2705305National Natural Science Foundation of China 82204052National Natural Science Foundation of China 82288102National Social Science Fund of China 23&ZD184Peking University Third Hospital BYSYDL2022001Peking University Third Hospital BYSYDL2024003
6 · The paper itself

Abstract

backgroundIntimate partner violence (IPV) and infertility are significant global health and human rights concerns. Evidence has shown that infertile women face a higher risk of IPV, yet national-level data on its prevalence remain limited. This study aims to quantify the prevalence of IPV against infertile women in China and identify associated risk factors.

methodsA national cross-sectional study was conducted in China from October 2021 to August 2022, using multistage stratified cluster sampling. Infertile women were recruited from 30 reproductive centers across ten provinces. A self-administered questionnaire, including the Revised Conflict Tactics Scale (CTS-2) and the Scale of Economic Abuse-12 (SEA-12), measured IPV in the past 12 months and over a lifetime. A structural equation model (SEM) explored risk factors for past-12-month IPV victimization.

resultsA total of 12,392 infertile women were included. The weighted 12-month prevalence of IPV was 34.1% (95% CI, 33.2%-34.9%) and lifetime prevalence was 44.2% (95% CI, 43.3%-45.1%). SEM identified female-factor infertility (standardized coefficient, 0.0473; P = .01) and ever-experienced infertility treatment failure (0.0774; P < .001) as direct drivers of 12-month IPV victimization. Other factors included the participant's unstable employment (0.0442; P = .006), non-nuclear family structure (0.0479; P = .01), and current male partner's adverse behaviours (0.5470; P < .001).

conclusionsGlobally, this is the first national-level study to examine IPV against infertile women, revealing a high prevalence rate in China. The findings underscored the need for gender-transformative interventions and policy measures, including improving access to infertility care, integrating IPV screening in clinical practice, and funding evidence-based research. Such approaches can reduce IPV, promote reproductive health, and advance health equity.

Indexed as

Infertility, FemaleIntimate Partner ViolenceAdultChinaCross-Sectional StudiesFemaleHumansMiddle AgedPrevalenceRisk FactorsSurveys and QuestionnairesYoung AdultHealth equityInfertilityIntimate partner violence

Identifiers

PMID41275218
PMCPMC12755016

What Socratic holds

Textmetadata
LicenceCC BY-NC-ND
Read underepoch 390

Registered trials

None linked

Read under generation 80e0d062 · epoch 390. Bibliography from PubMed, PubMed Central and OpenAlex; grants from NIH RePORTER; trial links from ClinicalTrials.gov; estimates, votes and beliefs from the Socratic graph.